Michael A. Metzger - 16 Dec 2021 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
President and COO, Director
Signature
/s/ Michael A. Metzger
Issuer symbol
SNDX
Transactions as of
16 Dec 2021
Net transactions value
-$1,050,501
Form type
4
Filing time
20 Dec 2021, 17:44:33 UTC
Previous filing
15 Dec 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Options Exercise $144,922 +22,715 +129% $6.38 40,374 16 Dec 2021 Direct
transaction SNDX Common Stock Sale $433,400 -22,715 -56% $19.08 17,659 16 Dec 2021 Direct F1, F2
transaction SNDX Common Stock Options Exercise $10,693 +1,676 +9.5% $6.38 19,335 17 Dec 2021 Direct
transaction SNDX Common Stock Sale $31,877 -1,676 -8.7% $19.02 17,659 17 Dec 2021 Direct F1, F3
transaction SNDX Common Stock Options Exercise $102,080 +16,000 +91% $6.38 33,659 20 Dec 2021 Direct
transaction SNDX Common Stock Sale $324,608 -16,000 -48% $20.29 17,659 20 Dec 2021 Direct F1, F4
transaction SNDX Common Stock Options Exercise $394,650 +45,000 +255% $8.77 62,659 20 Dec 2021 Direct
transaction SNDX Common Stock Sale $912,960 -45,000 -72% $20.29 17,659 20 Dec 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -22,715 -100% $0.000000* 0 16 Dec 2021 Common Stock 22,715 $6.38 Direct F5
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -1,676 -100% $0.000000* 0 17 Dec 2021 Common Stock 1,676 $6.38 Direct F5
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -45,000 -100% $0.000000* 0 20 Dec 2021 Common Stock 45,000 $8.77 Direct F5
transaction SNDX Stock Options (Right to buy) Options Exercise $0 -16,000 -100% $0.000000* 0 20 Dec 2021 Common Stock 16,000 $6.38 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 596,031 options to purchase shares of common stock that are vested and immediately exercisable and a total of 335,209 options to purchase shares of common stock that have not yet vested.
F2 The sale prices ranged from $19.00 to $19.30.
F3 The sale prices ranged from $19.00 to $19.06.
F4 The sale prices ranged from $19.17 to $21.01
F5 This option is fully vested.